Jeffrey A Bluestone

President and CEO of Sonoma Biotherapeutics; A. W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology. Made contributions to the biological basis of immunologic tolerance and to defining T-cell regulation in autoimmunity, including diabetes and transplantation. Former Founding Director of NIH-sponsored Immune Tolerance Network, Parker Institute for Cancer Immunotherapy and UCSF Diabetes Center. Awarded American Society of Transplantation/Roche Distinguished Scientist Award; Juvenile Diabetes Research Association's Mary Tyler Moore and Robert Levine Excellence in Clinical Research Award; the JDRF Grodsky Distinguished Basic Scientist Award; and American Association of Immunologists Mentorship Award.